| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11,0 M € | +11.4% | 9,9 M € | +16.7% | 8,4 M € | -35.0% | 13,0 M € | +5.4% | 12,3 M € | — | — | — | — | 26,1 M € | +8.3% | 24,1 M € | +24.7% | 19,3 M € | +7.5% | 18,0 M € | +17.0% | 15,4 M € | +22.5% | 12,5 M € | +430.8% | 2,4 M € | +245.2% | 684,9 k € | ||||||
| Gross margin | — | — | — | — | — | 2,3 M € | -6.1% | 2,5 M € | +18.5% | 2,1 M € | +17.1% | 1,8 M € | — | — | — | — | — | — | — | — | ||||||||||||||
| EBITDA | 291,5 k € | +168.6% | -424,8 k € | +63.2% | -1,2 M € | -2251.4% | -49,2 k € | -112.0% | 410,6 k € | +24.8% | 329,1 k € | +4.6% | 314,6 k € | -8.5% | 343,8 k € | +67.6% | 205,2 k € | -4.3% | 214,3 k € | +165.3% | 80,8 k € | +116.9% | -479,0 k € | -365.5% | 180,4 k € | -43.4% | 318,7 k € | +12.8% | 282,7 k € | +212.6% | -250,9 k € | -35.1% | -185,7 k € | |
| Operating profit | -25,3 k € | +96.4% | -710,6 k € | +53.4% | -1,5 M € | -338.2% | -347,6 k € | -642.9% | 64,0 k € | -0.2% | 64,2 k € | +19.2% | 53,8 k € | -54.3% | 117,7 k € | +988.3% | 10,8 k € | -64.7% | 30,7 k € | +127.8% | -110,4 k € | +83.7% | -678,0 k € | -3114.9% | -21,1 k € | -10.9% | -19,0 k € | +56.0% | -43,2 k € | +92.0% | -542,0 k € | -82.4% | -297,1 k € | |
| Profit/loss | -94,6 k € | +87.6% | -762,7 k € | +53.7% | -1,6 M € | -339.0% | -375,6 k € | -535.1% | 86,3 k € | +2.5% | 84,2 k € | +71.5% | 49,1 k € | -64.0% | 136,5 k € | +293.0% | 34,7 k € | +48.6% | 23,4 k € | +170.4% | -33,2 k € | +95.4% | -729,2 k € | -281.9% | -190,9 k € | -137.8% | -80,3 k € | +68.4% | -253,9 k € | +53.0% | -539,9 k € | -51.5% | -356,3 k € | |
| Equity | -1,7 M € | -5.9% | -1,6 M € | -91.6% | -832,3 k € | -201.9% | 816,5 k € | -31.5% | 1,2 M € | +3.1% | 1,2 M € | +2.7% | 1,1 M € | -0.4% | 1,1 M € | +7.9% | 1,0 M € | -1.8% | 1,1 M € | -2.7% | 1,1 M € | -7.3% | 1,2 M € | +615.6% | 165,3 k € | -60.3% | 416,7 k € | -30.0% | 595,0 k € | +464.7% | -163,2 k € | +44.6% | -294,8 k € | |
| Total assets | 28,9 M € | +38.1% | 20,9 M € | +12.5% | 18,6 M € | +7.2% | 17,4 M € | +141.8% | 7,2 M € | -1.7% | 7,3 M € | +4.0% | 7,0 M € | +2.2% | 6,9 M € | +19.4% | 5,8 M € | +6.8% | 5,4 M € | -5.7% | 5,7 M € | +46.7% | 3,9 M € | -50.1% | 7,8 M € | +8.3% | 7,2 M € | +15.9% | 6,2 M € | +57.8% | 3,9 M € | +24.0% | 3,2 M € | |
| Cash | 22,4 M € | +42.4% | 15,7 M € | +6.4% | 14,8 M € | +6.4% | 13,9 M € | +294.7% | 3,5 M € | +27.5% | 2,8 M € | -9.6% | 3,1 M € | +24.1% | 2,5 M € | +14.4% | 2,2 M € | +1.2% | 2,1 M € | +7.6% | 2,0 M € | +70.0% | 1,2 M € | -29.6% | 1,6 M € | +46.2% | 1,1 M € | +113.0% | 529,8 k € | +111.6% | 250,4 k € | +35.9% | 184,3 k € | |
| Debts | 30,5 M € | +36.6% | 22,3 M € | +15.2% | 19,4 M € | +17.5% | 16,5 M € | +185.1% | 5,8 M € | -4.8% | 6,1 M € | +4.5% | 5,8 M € | +2.3% | 5,7 M € | +21.0% | 4,7 M € | +9.4% | 4,3 M € | -6.6% | 4,6 M € | +72.4% | 2,7 M € | -65.1% | 7,6 M € | +12.4% | 6,8 M € | +20.7% | 5,6 M € | +37.1% | 4,1 M € | +18.8% | 3,5 M € | |
| Staff | 54 | 51,2 | 43,8 | 41,4 | 38,3 | 37,7 | 37,7 | 32,8 | 31,1 | 30,1 | 28,6 | 26,5 | 19,1 | 20,6 | 15,7 | 14,4 | 3,1 | |||||||||||||||||
Public limited company · La Louvière · incorporated on 28/04/2008 · 54,0 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+42.4%).
Solid counterparty for a standard engagement.
CENTRE SPECIALITES PHARMACEUTIQUES BENELUX is a Public limited company incorporated in 2008. Its main activity is: Warehousing and storage. Its registered office is in La Louvière. It employs on average 54,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette